Profund Advisors’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.63M Buy
42,885
+29,314
+216% +$1.24M 0.05% 246
2026
Q2
$638K Sell
13,571
-625
-4% -$15.4K 0.02% 468
2026
Q1
$268K Sell
14,196
-7,793
-35% -$132K 0.01% 824
2025
Q4
$294K Buy
21,989
+3,323
+18% +$41.1K 0.01% 887
2025
Q3
$220K Buy
18,666
+4,959
+36% +$46.2K 0.01% 924
2025
Q2
$89K Sell
13,707
-3,802
-22% -$25K ﹤0.01% 973
2025
Q1
$102K Buy
17,509
+5,216
+42% +$37.4K ﹤0.01% 952
2024
Q4
$85.6K Sell
12,293
-8,550
-41% -$58.8K ﹤0.01% 1081
2024
Q3
$119K Sell
20,843
-3
-0% -$21 ﹤0.01% 1097
2024
Q2
$150K Buy
+20,846
New +$182K 0.01% 1019
2022
Q1
– Sell
-785
Closed -$16K – 1388
2021
Q4
$16K Buy
785
+106
+16% +$3.38K ﹤0.01% 1372
2021
Q3
$24K Buy
+679
New +$29.4K ﹤0.01% 1349

Other funds holding DFTX

Profund Advisors's DFTX Position: Q3 2026 in Review

Profund Advisors increased its Definium Therapeutics (DFTX) stake by 216% in Q3 2026, buying an estimated $1.24M and bringing the position to 42,885 shares worth $1.63M. The position accounts for 0.05% of the portfolio, ranked #246.

Profund Advisors first reported a position in DFTX in Q3 2021 and has held it in 12 quarters since. 77 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Profund Advisors held 42,885 shares of Definium Therapeutics worth $1.63M as of Q3 2026.
  • Profund Advisors bought 29,314 Definium Therapeutics shares in Q3 2026, an estimated $1.24M.
  • Definium Therapeutics made up 0.05% of Profund Advisors's portfolio in Q3 2026, its #246 holding.
  • Profund Advisors first reported a position in Definium Therapeutics in Q3 2021 and has held it in 12 quarters since.
  • 77 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.